Novo Nordisk pushes insurers to cover Wegovy costs, seeking balance with direct sales. Demand soars for obesity drugs despite employer pushback. Medicare pilot launching in July offers $50 monthly access, aiming to solve cost trend concerns.
Novo Nordisk pushes insurers as weight-loss drug demand soars
✨ Enjoying this article? ✨
📱 Get more with the NewsNuggs iOS App →